Ketamine for pain
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The efficacy of the N-methyl-D-aspartate receptor antagonist ketamine as an analgesic agent is still under debate, especially for indications such as chronic pain. To understand the efficacy of ketamine for relief of pain, we performed a literature search for relevant narrative and systematic reviews and meta-analyses. We retrieved 189 unique articles, of which 29 were deemed appropriate for use in this review. Ketamine treatment is most effective for relief of postoperative pain, causing reduced opioid consumption. In contrast, for most other indications (that is, acute pain in the emergency department, prevention of persistent postoperative pain, cancer pain, and chronic non-cancer pain), the efficacy of ketamine is limited. Ketamine’s lack of analgesic effect was associated with an increase in side effects, including schizotypical effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
Peltoniemi, M. A., Hagelberg, N. M., Olkkola, K. T., & Saari, T. I. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0383-6 · Cited by 672
Ketamine: 50 Years of Modulating the Mind
Li, L., & Vlisides, P. E. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00612 · Cited by 385
Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man
Schüttler, J., Stanski, D. R., White, P. F., Trevor, A. J., Horai, Y., Verotta, D., & Sheiner, L. B. (1987) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01066320 · Cited by 178
Use of oral ketamine in chronic pain management: A review
Blonk, M. I., Koder, B. G., van den Bemt, P. M. L. A., & Huygen, F. J. P. M. (2010) · European Journal of Pain · doi:10.1016/j.ejpain.2009.09.005 · Cited by 168
MCNICOL, E. D., SCHUMANN, R., & HAROUTOUNIAN, S. (2014) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12377 · Cited by 167 · cited 1×
“McNicol et al. (2014)41 included all RCTs that administered ketamine by intravenous or epidural routes.”
BackgroundNiesters, M., Khalili-Mahani, N., Martini, C., Aarts, L., van Gerven, J., van Buchem, M. A., Dahan, A., & Rombouts, S. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31826a0db3 · Cited by 147
Self-citation
Cited by
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Williams, N. R., Heifets, B. D., Blasey, C., Sudheimer, K., Pannu, J., Pankow, H., Hawkins, J., Birnbaum, J., Lyons, D. M., Rodriguez, C. I., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18020138 · Cited by 519
A Word to the Wise About Intranasal Esketamine
Schatzberg, A. F. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19040423 · Cited by 96
“But ketamine has been reported to reduce the risk of tolerance with opioids (5) and, at anesthetic doses, to reduce postsurgery opioid use, likely through its NMDA antagonism effects (6).”
BackgroundEsketamine: new hope for the treatment of treatment-resistant depression? A narrative review
Salahudeen, M. S., Wright, C. M., & Peterson, G. M. (2020) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098620937899 · Cited by 72
Motoyama, Y., Oshiro, Y., Takao, Y., Sato, H., Obata, N., Izuta, S., Mizobuchi, S., & Kan, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-49360-1 · Cited by 26
Metadata
- Authors
- Jonkman, K., Dahan, A., van de Donk, T., Aarts, L., Niesters, M., & van Velzen, M.
- Venue
- F1000Research
- Publisher
- F1000 Research Ltd
- Published
- 2017-09-20
- Volume
- 6
- Pages
- 1711
- ISSN
- 2046-1402 (ISSN-L)
- OpenAlex
- W2754427945
- Cited by
- 61
- References
- 6
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ketamine for pain. https://app.cochat.ai/papers/10.12688/f1000research.11372.1
- The paper
- Jonkman, K., Dahan, A., van de Donk, T., Aarts, L., Niesters, M., & van Velzen, M. (2017). Ketamine for pain. F1000Research. https://doi.org/10.12688/f1000research.11372.1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.